United States · FDA National Drug Code directory
Fesoterodine Fumarate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62332-176_2fc9ba3f-2336-45b8-9020-bffc1298a6e0
- Product NDC
- 62332-176
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Fesoterodine Fumarate
- Labeler
- Alembic Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230106
- Source listing expiry
- 20261231
Source-listed ingredients
- FESOTERODINE FUMARATE — 8 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, EXTENDED RELEASE in 1 CARTON (62332-176-10) · 62332-176-10
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-176-30) · 62332-176-30
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-176-90) · 62332-176-90
- 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-176-91) · 62332-176-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →